Fuan Pharmaceutical (300194.SZ): "Injection grade Vancomycin Hydrochloride" has obtained a drug registration certificate.

Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary, Fuan Pharmaceutical Group Hubei Renmin Pharmaceutical Co., Ltd. (hereinafter referred to as "Renmin Pharmaceutical"), recently received a drug registration certificate issued by the National Medical Products Administration. The registered drug is "Vancomycin Hydrochloride for Injection." Vancomycin Hydrochloride for Injection is used for infections caused by methicillin-resistant Staphylococcus aureus and other bacteria, including sepsis, infective endocarditis, osteomyelitis, arthritis, superficial secondary infections of burns, surgical wounds, pneumonia, lung abscess, empyema, peritonitis, and meningitis.